ERBB2 and breast carcinoma: HER2+ can be a variable in HR+ breast cancer (tumour type is defined either as HR+HER+ or HR+HER−) or HR− breast cancer (either HR− HER+, or HER2−, HR− which is termed triple negative (TN) breast cancer).